Total Funding
28
Total FundingSeries C raised
Growth Score
pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4324282
Hyglos GmbH is a biotech company which develops bacteriophage-derived recombinant proteins for detection and removal of harmful bacteria.
Oliver Gluck: CFO
About the Company
As an established Biotech company, Hyglos is dedicated to exploit the biochemical principles evolved by bacteriophages for healthcare applications. The abundance of bacteriophages in nature and the unmet precision in occupying and destroying their host bacteria provide an almost unlimited pool for target-specific protein tools.
